Cryolipolysis, a non-invasive fat-reduction and body contouring technology, has been widely adopted in aesthetic clinics worldwide for its safety, efficiency, and minimal downtime. To ensure optimal treatment results, protect patient safety, and extend the service life of the equipment, strict adherence to the following usage precautions is mandatory for operators, clinics, and end-users. This guide applies to professional cryolipolysis devices for commercial aesthetic use and aligns with international medical aesthetic safety standards.
Pre-Treatment Patient Screening & Contraindications
Absolute contraindications must be strictly enforced; treatment is prohibited for individuals meeting any of the following criteria:
– Pregnancy & Lactation: Not suitable for pregnant, breastfeeding, or conception-planning individuals.
– Cold-Related Disorders: Patients with cryoglobulinemia, cold agglutinin disease, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud’s disease, or chilblains.
– Skin & Tissue Abnormalities: Open wounds, infected skin, severe eczema/dermatitis, psoriasis, active inflammation, recent surgical scars, hernias in or adjacent to the treatment area, or severe varicose veins.
– Implanted Medical Devices: Individuals with pacemakers, defibrillators, or other active electronic implants (treatment over implant sites is strictly forbidden).
– Neurological Conditions: Diabetic neuropathy, post-herpetic neuralgia, impaired skin sensation, or chronic pain disorders.
– Blood & Systemic Issues: Bleeding disorders, use of blood-thinning medications, severe obesity (BMI >40), autoimmune diseases, or fever/acute infections.
– Age Restrictions: Not intended for individuals under 18 years old.
Pre-Treatment Patient Preparation
1. Conduct a full medical history consultation and document all pre-treatment assessments; obtain written informed consent after disclosing potential side effects.
2. Avoid sun exposure, tanning, or sunburn on the treatment area for 2 weeks prior; sun-damaged skin increases complication risks.
3. Instruct patients to avoid applying body oils, perfumes, lotions, or cosmetics to the target area on treatment day.
4. Ensure the treatment area has a subcutaneous fat layer thickness of at least 1cm; do not treat overly thin areas.
5. Advise patients to avoid strenuous exercise, excessive alcohol intake, and large meals 24 hours before treatment.
Intra-Treatment Operational Safety Rules
Equipment Preparation
1. Place the device on a stable, flat, heat-resistant surface in a dry, well-ventilated room; keep away from water, heat sources, and flammable materials.
2. Inspect power cords, plugs, applicators, and cooling membranes before each use; do not operate damaged equipment (e.g., frayed cords, cracked membranes, faulty cooling systems).
3. Use only original manufacturer-provided accessories (gel pads, applicators, membranes); unauthorized parts may cause frostbite or equipment failure.
4. Disinfect all applicators and contact components with medical-grade disinfectants per clinical hygiene standards; ensure full drying before use.
Treatment Operation Protocols
1. Apply dedicated anti-frostbite gel pads evenly to the treatment area; never place applicators directly on bare skin.
2. Set temperature, vacuum pressure, and treatment duration per the device manual and patient fat thickness; avoid excessive cooling or prolonged single-area treatment.
3. Do not treat large adjacent body areas in one session (or within 1–2 months); over-treatment may cause metabolic disorders or acidosis.
4. Monitor the patient’s skin condition and comfort level continuously; pause treatment immediately for severe stinging, numbness, or skin discoloration.
5. Keep applicators moving slightly as needed; avoid fixed positioning that may cause localized frostbite.
6. Operate with dry hands; do not touch power components with wet hands to prevent electric shock.
Post-Treatment Care Guidelines for Patients
1. Immediate Aftercare: Gently massage the treated area for 5–10 minutes to promote lymphatic circulation; redness, swelling, bruising, or mild numbness is normal and resolves within 1–3 weeks.
2. Temperature Avoidance: No hot baths, saunas, steam rooms, or extreme cold exposure for 72 hours post-treatment; heat/cold may exacerbate skin irritation.
3. Sun Protection: Avoid direct sun exposure or tanning for 2 weeks; apply broad-spectrum sunscreen to prevent pigmentation.
4. Lifestyle & Activity: Wear loose, breathable clothing; avoid tight compression on the treated area. No strenuous exercise for 48 hours; maintain a balanced diet and hydration for optimal fat metabolism.
5. Symptom Monitoring: Advise patients to contact a physician immediately for persistent severe pain, blistering, skin ulceration, hardening of fat tissue (paradoxical adipose hyperplasia), or abnormal swelling.
Equipment Maintenance & Storage
1. Post-Use Cleaning: Disinfect applicators and accessories after each session; wipe the device body with a soft, dry cloth (do not immerse in water or use corrosive cleaners).
2. Regular Maintenance: Schedule professional servicing every 3–6 months to inspect cooling systems, vacuum pumps, and electrical components; replace worn parts promptly.
3. Storage Conditions: Store in a cool (5–30°C), dry, dust-free environment; avoid direct sunlight, high humidity, and physical impact.
4. Power Management: Unplug the device when not in use; do not leave it powered on for extended idle periods.
5. Transportation: Secure applicators and accessories during transit; avoid vibration or dropping to prevent internal component damage.
Legal & Compliance Notes
1. This device is for professional aesthetic clinic use only; not for household, self-treatment, or unauthorized resale.
2. Operators must complete official training and obtain certification before use; untrained personnel are prohibited from operating the equipment.
3. Comply with local medical aesthetic regulations, FDA/CE marking requirements, and regional health authority standards.
4. Do not modify the device’s internal structure or software; unauthorized modifications void warranties and pose safety hazards.
5. Retain all treatment records, equipment maintenance logs, and patient consent forms for regulatory inspections.
Final Reminder
Cryolipolysis safety and efficacy depend on standardized operation, strict patient screening, and proper aftercare. Prioritize patient safety over treatment speed, and follow all precautions outlined above. For device malfunctions or clinical emergencies, contact the manufacturer’s technical support immediately and cease use until repairs are completed.